The Non-Adherence Label

As the American health care system has diminished its capacity to ask the right questions, it has drifted toward interventions that are inevitably ineffective, inefficient, and costly.

Pharmaceutical companies unveil new medications as if they were modern miracles, inviting viewers to ask their doctors about them. Yet the “ask” that follows is rarely an inquiry. It arrives in the clinics as a demand shaped by advertising, not understanding. Physicians allotted ten hurried minutes, become less guides through complexity and more gatekeepers under pressure.

There is no space to explore how drugs work, what risks accompany their benefits, what long‑term consequences might unfold, or whether gentler, more appropriate alternatives exist. In these compressed encounters, curiosity collapses into consumption, and the shared work of discernment is replaced by a transaction neither patients nor doctors truly chose.

Once the clinicians, pressed for time and faced with patients whose minds are already made up, sign the prescription with multiple refills, the rest of the process unfolds almost automatically; patients arrive at the pharmacy expecting relief, not complexity. The brand‑name copay is shockingly high, even with insurance. Pharmacists explain that the cost is tied to the drug being new, non‑formulary, or both. Patients bring the medications home and take the first dose, then the second, then the third.

Often, one of three broad outcomes appear; side effects emerge, the ones never discussed, never asked about, or never understood; adverse effects appear, rare but real; nothing happens at all, no harm, but also no improvement, revealing that the medication was never aligned with the patients’ conditions or biology.

As a result, patients often decide to skip doses, stop early, double up, or abandon the medications entirely.

Sometimes patients do everything “right.” They take the medication as prescribed. They follow the plans. And then, without warning; copays are suddenly far higher than before. Or the medications are no longer covered at all. Or the refills require new appointments with doctors for authorization renewal. Or the insurers have quietly moved the drug to a different tier. Or medications slip into shortage when demand rises faster than pharmacies can supply them.

Patients feel caught in a structural ambush, discovering that the system they assumed was stable is in fact ever‑changing, opaque, and indifferent to continuity.

Patients are expected to be consistent even when; the price is inconsistent, the coverage is inconsistent, the communication is inconsistent, the rules are inconsistent.

The unfilled refills become evidence of a system’s design that makes discontinuation more likely than adherence. Stopping the medication, in many cases, is not a failure of discipline. It is a rational response to an irrational structure.

Patients’ initial desires were shaped by advertising. Clinicians’ decisions were shaped by time pressures. Pharmacists’ explanations were shaped by formulary rules. Patients’ experiences were shaped by situations or biology. Stopping medications was shaped by real life’s volatility.

The shift from non‑compliant to non‑adherent was framed as a move toward gentler, less punitive language. But the underlying logic remained unchanged. Both terms perform the same function; they mark the patient as the point of failure. They erase the structural, financial, emotional, and informational forces that shaped the patient’s choices.

Once the label is applied, the question shifts from “Why did this happen?” to “How do we correct the patient?” The system’s response becomes operational rather than relational.

Costly, ineffective, inefficient interventions emerge; constant reminders, texts, calls, app notifications, automated messages. Relentless outreach; care coordinators, pharmacists, nurses, all tasked with “closing the gap.” Adherence plans; flowcharts, dashboards, metrics, and performance indicators. Team meetings; groups of professionals discussing the patient as a problem to be solved.

Once the label is applied, the system begins to generate flawed explanations that protect its own architecture. The plan was sound; the patient deviated. The medication is effective; the patient failed to take it. The system provided access; the patient did not use it. The outreach was thorough; the patient ignored it.

The system keeps generating activity without generating understanding and results.

Patients are the only ones who know why the medication was stopped. Yet the system rarely asks them. Instead, it consults data dashboards, claims reports, pharmacy refill histories, predictive models, committee meetings, quality metrics.

A system that does not ask the right questions cannot produce the correct answers. It produces defective interventions. Therefore, interventions without sound inquiry become a form of institutional blindness.

When a system designs solutions without understanding causes, it reveals several things about itself; It is optimized for throughput, not reflection. It is structured around efficiency, not empathy. It is built to correct, not to comprehend. It is designed to protect its own logic, not to question it. It is more comfortable with labels than with stories.

This is why the non-adherent label is so powerful: it allows the system to stop asking the right questions.

Byron Batz, Ph.D.

© 2026 Byron Batz. All rights reserved.

No part of this work may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the author, except in the case of brief quotations used in reviews, academic work, or other permitted uses under copyright law.

The Racial Label

The healthcare system in the United States often makes a fundamental category error: it tries to understand South Americans, Central Americans, Mexicans, Caribbean peoples, and their descendants (SCMCa+) through a single, flattened label. This impulse toward simplification is not unique to this group; it is a recurring pattern in how large institutions approach many racialized communities.

What these labels, Hispanic, Latino, Latinx, Latine, or the even more reductive habit of calling everyone “Mexican,” fail to grasp is that identity in Spanish‑speaking worlds is not anchored in a monolithic essence. It is woven from regional histories, cultural lineages, social worlds, and lived experiences that vary dramatically from one community to another.

To collapse this plurality into a single term is a narrowed view. It treats identity as something that can be managed from the outside without understanding the inner worlds that shape a life. It assumes that people can be understood by the convenience of a category rather than by the texture of their culture: norms, customs, beliefs, arts, experiences, social practices, and behaviors.

The cultural complexity is immense, but not in the way bureaucracies imagine complexity, as a problem to be managed or a dataset to be standardized. It is immense because it reflects the many trajectories through which a people become themselves.

A first‑generation Spanish‑only speaker is not simply a “language barrier”; they are the living continuation of a homeland’s memory. A second‑generation bilingual speaker carries the tension and creativity of two linguistic worlds at once; trying to unify both. A third‑generation English‑only descendant may feel the pull of ancestral regions they have never visited but still inhabit through family, food, ritual, or story.

The health care system and its organizations often confuse the horizon for the narrow view, and once the view narrows, the programs that emerge from it narrow as well. A program designed from a single vantage point may flourish in one region of the United States and fail spectacularly in another, not because the people are “hard to reach,” but because the institution never learned to see them in the first place.

This is where the USDA plant‑hardiness zones offer more than a convenient metaphor. Even the land itself refuses to be understood through a single category. The United States is divided into thirteen zones, each split again into sub‑zones, not because botanists enjoy complexity, but because life requires it. A plant that thrives in Zone 9b will wither in Zone 5a, not due to any flaw in the plant, but because the environment demands a different kind of care.

What the hardiness map teaches is the condition for life. The soil, the temperature, the seasonal rhythms, the invisible histories of a place all shape what can grow there. To ignore these differences is to error about the nature of living systems.

The US health care system often assumes that a single cultural program, a single outreach strategy, a single linguistic template can be transplanted across the country and bear fruit everywhere. But people are shaped like ecosystems.

When institutions insist on uniformity, they flatten reality. They confuse what is easy to administer with what it means to be fully human.

Just as a gardener must understand the land before planting, a health system must understand the lived worlds of the communities it serves. Not as categories, but as climates. Not as labels, but as ecosystems of meaning. The failure to do so is ontological. It reveals a worldview that treats people as interchangeable units rather than as beings rooted in specific soils of experience.

Yet the U.S. healthcare system continues to compress SCMCa+ communities into restrictive, single, non‑inclusive labels, as if the complexity of entire hemispheric histories could be folded into a checkbox. These labels, however well‑intentioned, function less as descriptors and more as administrative shortcuts. They tell institutions what is easiest to record, not what is truest about the people they claim to serve.

This is why adopting an inclusive acronym such as SCMCa+ acknowledges that the Spanish‑speaking world and its diasporas are not a demographic block but a constellation of identities shaped by region, music, food, folklore, and history. The “+” matters because the story is never finished.

Existing labels are not inaccurate so much as they are built on the assumption that identity can be defined and managed from above or from the outside. They presume that people can be understood through the logic of classification rather than through the logic of recognition.

A system relying on reductive labels is not simply misnaming communities; it is misapprehending what identity is. Identity is relational, not categorical. Identity is historical, not static. Identity is lived, not assigned.

SCMCa+ gestures toward this truth by refusing to collapse plurality into sameness. It signals that any attempt to understand these communities must begin with their complex internal diversity rather than simplified superficial similarities.

Byron Batz, Ph.D.

© 2026 Byron Batz. All rights reserved.

No part of this work may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the author, except in the case of brief quotations used in reviews, academic work, or other permitted uses under copyright law.